<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jmg.bmj.com">
<title>Journal of Medical Genetics Somatic mosaicism</title>
<link>http://jmg.bmj.com</link>
<description>Journal of Medical Genetics RSS feed -- recent Somatic mosaicism articles</description>
<prism:eIssn>1468-6244</prism:eIssn>
<prism:publicationName>Journal of Medical Genetics</prism:publicationName>
<prism:issn>0022-2593</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jmg.bmj.com/cgi/content/short/62/6/405?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.jmg.bmj.com/homepage/JMG_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.jmg.bmj.com/homepage/JMG_95x60.gif">
<title>Journal of Medical Genetics</title>
<url>http://hwmaint.jmg.bmj.com/homepage/JMG_95x60.gif</url>
<link>http://jmg.bmj.com</link>
</image>
<item rdf:about="http://jmg.bmj.com/cgi/content/short/62/6/405?rss=1">
<title><![CDATA[Analysing tumours for genetic diagnosis in mosaic neurofibromatosis type 1]]></title>
<link>http://jmg.bmj.com/cgi/content/short/62/6/405?rss=1</link>
<description><![CDATA[
<p>Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disorder caused by pathogenic variants in the <I>NF1</I> gene, resulting in diverse clinical manifestations, especially multiple cutaneous neurofibromas. In approximately 50% of cases, variants occur de novo, and a portion of these cases involves genetic mosaicism, where variants are present in a subset of cells of an individual. Mosaic NF1 often presents with a milder phenotype and reduced transmission risk, complicating clinical diagnosis and genetic consulting. Conventional blood-based genetic testing may fail to detect the pathogenic variants in mosaic cases, necessitating additional analysis using tumour-derived DNA. We present five such cases and suggest a comprehensive diagnostic workflow focusing on tumour-based analysis for mosaic cases.</p>
]]></description>
<dc:creator><![CDATA[Hartung, T. I., Kluwe, L., Farschtschi, S. C.]]></dc:creator>
<dc:date>2025-05-27T03:00:29-07:00</dc:date>
<dc:identifier>info:doi/10.1136/jmg-2024-110580</dc:identifier>
<dc:identifier>hwp:master-id:jmedgenet;jmg-2024-110580</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Analysing tumours for genetic diagnosis in mosaic neurofibromatosis type 1]]></dc:title>
<prism:publicationDate>2025-06-01</prism:publicationDate>
<prism:section>Somatic mosaicism</prism:section>
<prism:volume>62</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>405</prism:startingPage>
<prism:endingPage>408</prism:endingPage>
</item>
</rdf:RDF>